NEW YORK (GenomeWeb) – Cambridge Isotope Laboratories has announced a deal with IROA Technologies to develop and distribute metabolite quantitation kits for mass spectrometry-based profiling.
Under the terms of the agreement, the partners will work on IROA's Biochemical Quantitation Kits, which chemically label metabolites for isotopic ratio outlier analysis. In a statement, the firms said the kits can help researchers eliminate technical and analytical variance, thus increasing reliability.
Financial and other terms of the agreement were not disclosed.
A year ago, Ann Arbor, Michigan-based IROA signed an exclusive distribution deal for the Mass Spectrometry Metabolite Library of Standards with Sigma-Aldrich, now known in the US as MilliporeSigma following its acquisition by Merck KGaA.
Tewksbury, Massachusetts-based Cambridge Isotope Labs has commercialization deals with several proteomic- and metabolomic-focused companies, including Nexomics and MRM Proteomics.